179 related articles for article (PubMed ID: 12603267)
1. Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum.
Porras G; De Deurwaerdère P; Moison D; Spampinato U
Eur J Neurosci; 2003 Feb; 17(4):771-81. PubMed ID: 12603267
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
3. Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens.
De Deurwaerdère P; Moison D; Navailles S; Porras G; Spampinato U
J Neurochem; 2005 Jul; 94(1):140-9. PubMed ID: 15953357
[TBL] [Abstract][Full Text] [Related]
4. Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine.
Porras G; Di Matteo V; De Deurwaerdère P; Esposito E; Spampinato U
Neuropharmacology; 2002 Dec; 43(7):1099-109. PubMed ID: 12504916
[TBL] [Abstract][Full Text] [Related]
5. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
[TBL] [Abstract][Full Text] [Related]
6. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
[TBL] [Abstract][Full Text] [Related]
7. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated.
Lucas G; De Deurwaerdère P; Porras G; Spampinato U
Neuropharmacology; 2000 Aug; 39(11):1984-95. PubMed ID: 10963742
[TBL] [Abstract][Full Text] [Related]
8. 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.
Genova LM; Hyman SE
Synapse; 1998 Sep; 30(1):71-8. PubMed ID: 9704883
[TBL] [Abstract][Full Text] [Related]
9. The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.
Roczniak W; Babuśka-Roczniak M; Kwapuliński J; Brodziak-Dopierała B; Widuchowski W; Cipora E; Nowak P; Oświęcimska JM
Pharmacol Rep; 2015 Feb; 67(1):146-51. PubMed ID: 25560589
[TBL] [Abstract][Full Text] [Related]
10. Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes.
Yi SJ; Gifford AN; Johnson KM
Eur J Pharmacol; 1991 Jun; 199(2):185-9. PubMed ID: 1835440
[TBL] [Abstract][Full Text] [Related]
11. Central serotonin(2B) receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow.
Devroye C; Cathala A; Di Marco B; Caraci F; Drago F; Piazza PV; Spampinato U
Neuropharmacology; 2015 Oct; 97():329-37. PubMed ID: 26116760
[TBL] [Abstract][Full Text] [Related]
12. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat.
Bonhomme N; De Deurwaèrdere P; Le Moal M; Spampinato U
Neuropharmacology; 1995 Mar; 34(3):269-79. PubMed ID: 7543190
[TBL] [Abstract][Full Text] [Related]
13. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.
Zazpe A; Artaiz I; Del Río J
Br J Pharmacol; 1994 Nov; 113(3):968-72. PubMed ID: 7858893
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats.
Szumlinski KK; Frys KA; Kalivas PW
Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437
[TBL] [Abstract][Full Text] [Related]
15. Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum.
De Deurwaerdère P; L'hirondel M; Bonhomme N; Lucas G; Cheramy A; Spampinato U
J Neurochem; 1997 Jan; 68(1):195-203. PubMed ID: 8978726
[TBL] [Abstract][Full Text] [Related]
16. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration.
King GR; Xiong Z; Ellinwood EH
Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709
[TBL] [Abstract][Full Text] [Related]
17. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
Di Matteo V; Pierucci M; Esposito E
J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
[TBL] [Abstract][Full Text] [Related]
18. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
19. Differential serotonergic inhibition of in vitro striatal [3H]acetylcholine release in prenatally cocaine-exposed male and female rats.
Bolaños CA; Trksak GH; Cohen OS; Jackson D
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1339-48. PubMed ID: 12502023
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
